Company intelligence / Profile preview

PharmaNest

Princeton, New Jersey, USAfibronest.com ↗
Ownership
Private
Employees
~49
Development stage
Other
01

Overview

PharmaNest’s platforms have been validated across more than 20 preclinical models and multiple clinical studies in NASH/MASH, cirrhosis, HCC, and other fibrotic diseases. Their technology enables automated quantification of over 40 traits (+350 parameters) at the single-fiber level from standard collagen-stained slides. Clinical collaborations have demonstrated that their digital biomarkers can detect treatment effects with performance comparable to or exceeding manual histopathology assessment[5][8]. The platforms are currently for research use only.

Therapeutic areas
PulmonologyDermatologyGastroenterologyOncologyOtherNephrologyRheumatologyCardiovascular
Modalities
Device (digital pathology/image analysis platform)Non-pharmacological therapy (enabling technology for drug development, not a therapeutic itself)
Industry
Pathology
02

Partnerships

Icahn School of Medicine at Mount SinaiBristol Myers SquibbGalectin TherapeuticsSagimet Biosciences

Beyond the preview

Go deeper on PharmaNest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaNest.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call